Intrexon Corp., 10% Owner at Synthetic Biologics, Inc. (SYN), sold 150,565 shares at $0.67 ($99K) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $99k SYN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.67 | 11,413 | $8K | 7.7% |
| 2 | $0.67 | 30,265 | $20K | 20.5% |
| 3 | $0.66 | 3,737 | $2K | 2.5% |
| 4 | $0.66 | 9,909 | $7K | 6.6% |
| 5 | $0.65 | 26,080 | $17K | 17.2% |
| 6 | $0.65 | 69,161 |
| $45K |
| 45.5% |
| Total | $0.66 avg | 150,565 | $99K | 100% |
| Filing → |
| FCSC | BUY | 2017-12-13 | $4.2M | — | Filing → |
| AQB | BUY | 2017-01-20 | $25.0M | — | Filing → |
| OGEN | BUY | 2016-07-05 | $2.4M | — | Filing → |